Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MoonLake Immunotherapeutics
MLTX | US
16.93
USD-0.29
-1.68%
MLTX | US
About MoonLake Immunotherapeutics
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
23/04/2026
Close
16.93
Open
17.34
High
17.44
Low
16.78
MoonLake Immunotherapeutics a clinical-stage biopharmaceutical company engages in developing therapies. It is developing Sonelokimab a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa psoriatic arthritis ankylosing spondylitis or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug Switzerland.
View LessMLTX | US
Risk
81.4
Sharpe
-0.53
Luna's Score
40/100
Recommendation
Sell
Luna says (MLTX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
57.0%1 month
81.4%3 months
60.7%6 months
84.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.91
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-41.53
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-78.35M
MarketCap
1.06B
MarketCap(USD)
1.06B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-11.32
Short ratio
26.00
Short perc.
30.86
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
3.21
Range1M
3.96
Range3M
5.26
Volumes: Market Activity
Rel. volume
0.51
Price X volume
10.83M
